Shandong Weigao repurchases shares, treasury holdings increase

Shandong Weigao Group Medical Polymer Company Limited, a company listed on the Hong Kong Stock Exchange, announced its monthly return on movements in securities for June 2025. The report details a net decrease of 1,304,000 in issued ordinary H shares, excluding treasury shares, while treasury shares increased by 1,304,000. These transactions were conducted through a series of repurchases throughout the month at prices ranging from HKD5.2498 to HKD6.135 per share. Consequently, the total number of issued shares stands at 4,522,332,324, with 8,132,400 held as treasury shares. The company's authorized share capital remains at RMB457,063,232.4, comprising both listed H shares and unlisted shares.